Jove
Visualize
联系我们
JoVE
x logofacebook logolinkedin logoyoutube logo
关于 JoVE
概览领导团队博客JoVE 帮助中心
作者
出版流程编辑委员会范围与政策同行评审常见问题投稿
图书馆员
用户评价订阅访问资源图书馆顾问委员会常见问题
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experiments存档
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教师资源中心教师网站
使用条款与条件
隐私政策
政策

相关概念视频

Hematopoiesis01:21

Hematopoiesis

The process of blood cell formation is called hematopoiesis. Hematopoiesis starts early during development, on the seventh day of embryogenesis. This phase of hematopoiesis is called the primitive wave, wherein the extraembryonic yolk sac allows the production of erythroid cells and endothelial cells from a common precursor called hemangioblast. The erythroid cells provide oxygen to support the growth of the rapidly dividing embryo. Hemangioblasts later develop into hematopoietic stem cells or...
Multipotency of Hematopoietic Stem Cells01:19

Multipotency of Hematopoietic Stem Cells

The hematopoietic stem cells or HSCs are multipotent, meaning they can differentiate and give rise to all blood and immune cells. HSCs are maintained in the quiescent stage until an external stimulus initiates their differentiation. The multipotent HSCs exist as two heterogeneous populations, long-term repopulating cells (LTRC) and short-term repopulating cells (STRC). The two HSC populations have different surface markers or receptors and are classified based on quiescence and long-term...
Differentiation of Common Myeloid Progenitor Cells01:15

Differentiation of Common Myeloid Progenitor Cells

Common myeloid progenitors (CMPs) are oligopotent cells that can differentiate into granulocytes and macrophages. Granulocytes and macrophages are essential for protecting the body against bacterial, viral, or fungal infections. They migrate from the bone marrow into the circulating blood to reach specific tissue sites where they differentiate and help in immune surveillance. However, they survive only for a few days and must be continuously made available to the organism to maintain a robust...
Regulation of Hematopoietic Stem Cells01:01

Regulation of Hematopoietic Stem Cells

All blood and immune cells are produced from the multipotent hematopoietic stem cells (HSCs) by the process of hematopoiesis. However, they all have a limited life span. In addition, many are depleted in immune surveillance or combatting an injury or infection. This makes blood one of the most regenerative tissues. Hematopoiesis helps replenish these blood and immune cells, restoring the body's normal functioning. However, overproduction of blood and immune cells can make them cancerous or...
Production of Formed Elements01:34

Production of Formed Elements

Hemangioblasts are multipotent stem cells originating from the mesoderm. They give rise to hematopoietic stem cells (HSCs), which undergo hematopoiesis to produce all the formed elements of blood. This process is regulated by a complex network of hematopoietic growth factors, including transcription factors, growth factors, and cytokines. These factors stimulate the HSCs to divide and differentiate, though some HSCs remain undifferentiated to maintain a self-renewing pool.
Most HSCs commit to...
Disorders of Erythrocytes01:27

Disorders of Erythrocytes

Disorders of erythrocytes, or red blood cells (RBCs), include a range of conditions affecting their number, shape, or function.
Erythrocyte disorders can be broadly categorized into two main types: anemic and polycythemic conditions.
A low oxygen-carrying capacity of the blood due to the loss, lower production, or destruction of erythrocytes is termed anemia. Hemorrhagic anemia, for example, occurs when bleeding from an external wound or internal ulcer reduces erythrocyte counts.
On the other...

您也可能阅读

相关文章

通过共同作者、期刊和引用图与本文相关的文章。

排序
Same author

FNBP1 in Chronic Myeloid Leukemia: Spatial Association with BCR-ABL and Potential Implications for Targeted Therapy.

Experimental oncology·2026
Same author

THE UBIQUITIN-PROTEASOME SYSTEM IN CANCER: MECHANISMS, TARGETS AND THERAPEUTIC POTENTIAL.

Experimental oncology·2026
Same author

Custom-made fibular cradle plate to optimise bone positioning for implant placement, restore maxillary contour, and preserve pedicle length in reconstruction of the maxilla.

The British journal of oral & maxillofacial surgery·2025
Same author

Drug management of TB in the intensive care setting: an international multicentre study.

The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease·2025
Same author

The superficial radial artery-a cautionary tale of two pedicles.

International journal of oral and maxillofacial surgery·2025
Same author

Impact of heteroresistance on treatment outcomes of people with drug-resistant TB.

IJTLD open·2024

相关实验视频

Updated: Jul 6, 2026

Generation of Immature, Mature and Tolerogenic Dendritic Cells with Differing Metabolic Phenotypes
06:09

Generation of Immature, Mature and Tolerogenic Dendritic Cells with Differing Metabolic Phenotypes

Published on: June 22, 2016

人类血液中主要的1型干扰素生成细胞的性质.

F P Siegal1, N Kadowaki, M Shodell

  • 1Saint Vincents Hospital and Medical Center, New York, NY 10011, USA.

Science (New York, N.Y.)
|June 12, 1999
PubMed
概括
此摘要是机器生成的。

科学家们确定了天然干扰素产生细胞 (IPC) 是一种罕见的树突细胞前体 (pDC2). 这些pDC2s是关键的效应细胞,产生大量的干扰素来对抗病毒和瘤威胁.

更多相关视频

Generation of Human Monocyte-derived Dendritic Cells from Whole Blood
07:35

Generation of Human Monocyte-derived Dendritic Cells from Whole Blood

Published on: December 24, 2016

Pan-myeloid Differentiation of Human Cord Blood Derived CD34+ Hematopoietic Stem and Progenitor Cells
10:25

Pan-myeloid Differentiation of Human Cord Blood Derived CD34+ Hematopoietic Stem and Progenitor Cells

Published on: August 9, 2019

相关实验视频

Last Updated: Jul 6, 2026

Generation of Immature, Mature and Tolerogenic Dendritic Cells with Differing Metabolic Phenotypes
06:09

Generation of Immature, Mature and Tolerogenic Dendritic Cells with Differing Metabolic Phenotypes

Published on: June 22, 2016

Generation of Human Monocyte-derived Dendritic Cells from Whole Blood
07:35

Generation of Human Monocyte-derived Dendritic Cells from Whole Blood

Published on: December 24, 2016

Pan-myeloid Differentiation of Human Cord Blood Derived CD34+ Hematopoietic Stem and Progenitor Cells
10:25

Pan-myeloid Differentiation of Human Cord Blood Derived CD34+ Hematopoietic Stem and Progenitor Cells

Published on: August 9, 2019

科学领域:

  • 免疫学 免疫学 免疫学
  • 细胞生物学 细胞生物学
  • 病毒学 病毒学

背景情况:

  • 干扰素 (IFN) 是抗病毒免疫中的关键细胞因子.
  • 自然的IFN产生细胞 (IPC) 很少见,难以分离,易发生亡.
  • IPCs表达CD4和MHCII类,但缺乏特定的血统标记.

研究的目的:

  • 为了识别和描述人类血液中难以捉摸的天然IFN生产细胞 (IPC).
  • 为了确定负责显著IFN生产的特定细胞类型.

主要方法:

  • 隔离和净化罕见的血液细胞.
  • 使用细胞表面标记物 (CD4,CD11c) 的表型表征.
  • 在微生物挑战后IFN生产能力的评估.

主要成果:

  • 纯化的IPC被确定为CD4 ((+) CD11c-类型2树突细胞前体 (pDC2s).
  • pDC2s表现出异常高的IFN产量 (比其他血液细胞大200-1000倍).

结论:

  • pDC2s是人类血液中主要的天然IFN生产细胞.
  • 这些细胞是对抗病毒和抗瘤反应的先天免疫力的关键效应细胞.